| Nome |
# |
|
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs, file bc2e38a4-236b-4566-b962-e8aad9c5a667
|
52
|
|
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19, file 0d1d2cdb-0140-4fff-a172-dc3874881a2c
|
33
|
|
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases, file d97de9fd-a130-46da-9afb-02087da98199
|
24
|
|
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study, file 84dd7b58-3cea-4c79-a51d-8bd0d6ed9c74
|
21
|
|
The interferon landscape along the respiratory tract impacts the severity of COVID-19, file 5c4f078d-498b-4b0a-a485-1a56ca00c5d1
|
15
|
|
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies, file fb0b486a-567c-46fb-8f4a-9da7fa2b9115
|
14
|
|
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials, file c225f9af-3ce9-487d-b6c4-fbb6c911cf9b
|
12
|
|
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections, file d4103d9a-c2aa-4851-a1bf-6c08e626b66e
|
11
|
|
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein, file 9e989b9d-e386-43fa-8302-2ba159594996
|
10
|
|
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies, file b779404e-30cb-4b11-ad88-620fd7643ee4
|
10
|
|
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2, file d054f41e-2663-48f5-bf52-cd1862c015ac
|
10
|
|
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection, file ef0b7103-711c-4126-9006-1c752b83ced2
|
10
|
|
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes, file 79f748a9-a106-41b5-bbb1-a99a722ed9d2
|
9
|
|
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?, file d83e9edf-4fac-4537-a204-8c6996ff0878
|
9
|
|
Answer to photo quiz: Streptococcus pneumoniae, file e8b2c167-702e-482e-b924-4e1757d121be
|
9
|
|
Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies, file eeb43155-8c7d-443d-b98c-5cb5516f2368
|
9
|
|
Molecular Cloning of a Human Monoclonal Antibody neutralizing a broad range of H1 subtype influenza virus including swine-origin influenza virus (S-OIV), file 08fabcaf-fe84-49f6-9aa9-7b62007ea5ec
|
8
|
|
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens, file 39e7dea4-d600-44d2-9b0e-f9a20d53cb8d
|
8
|
|
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses, file 56065a20-8f95-4a02-bff4-fc0c9064ad41
|
8
|
|
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation, file 9d3868e8-ab71-4a00-a44e-89eeb60e43ef
|
8
|
|
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia, file 2327d9d0-6590-4bde-88ca-09f4e4fcd24c
|
7
|
|
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection, file 2f9c145e-7d09-433b-8367-4e2634cd17bb
|
7
|
|
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients, file 3924a255-20fc-40f1-82de-b8f98c18dabf
|
7
|
|
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab, file 6de40274-d8f4-432f-bd60-1a3d7ab5dccc
|
7
|
|
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines, file 8c75dff2-e831-438b-a472-12e771cb5d09
|
7
|
|
A biologically-validated HCV E1E2 heterodimer structural model, file 1a8cf480-7d57-45bc-9dd3-a08e8897cfc6
|
6
|
|
HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role, file 603decb1-0659-4142-8c14-bfb0e7153320
|
6
|
|
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII), file 9e38996c-40c4-49f1-add0-3d72e318ea1e
|
6
|
|
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?, file dc571a09-f3af-4448-992a-019d7a0fa6af
|
6
|
|
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro, file e7b146e3-10ec-4a1c-8416-fb111bc52858
|
6
|
|
Rational dosing strategies of colistin: what about resistance?, file 299a08b1-3a5f-4716-b03d-34d4342279b5
|
5
|
|
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes, file ededbe18-89df-401f-9ebc-43c4f1296b52
|
5
|
|
Human Monoclonal Antibody able to nneutralize a broad range of H1 and H3 subtype influenza A viruses, file edfa3932-dba2-4958-90f1-6ab92edc35c3
|
5
|
|
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients, file f3341403-8767-46d5-a804-fbeb7d8bc302
|
5
|
|
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes, file 38cc88f2-7746-4b8d-b077-b8f0b62038a5
|
4
|
|
The interferon landscape along the respiratory tract impacts the severity of COVID-19, file a65df668-73fe-4407-afca-70d31b6155f6
|
4
|
|
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room, file 5b91c34f-c440-4f58-9a47-62d38e420244
|
3
|
|
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death, file 74022b23-9a0c-4ee5-8fa3-063c1ff98c70
|
3
|
|
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice, file 47c621a9-3b8f-4228-b750-b2d6dd1f3d24
|
2
|
|
Risks of "blind" automated identification systems in medical microbiology, file 551beded-d9dd-440e-b48d-e704924949c7
|
2
|
|
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle, file 81c8a000-ba13-4974-ac13-979a90227dbd
|
2
|
|
Viral respiratory pathogens and lung Injury, file a109b825-cdd7-44cc-9c14-36db62fc98a7
|
2
|
|
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients, file c745e7bc-8126-4172-b3fa-624ba17cbe0a
|
2
|
|
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study), file f785af42-2547-4b82-bd13-66e9295b28e7
|
2
|
|
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects, file fb2f5334-9f0f-453e-a04a-d22d5a27225e
|
2
|
|
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes, file 18020ace-7d73-4352-acf5-5a825c1e7cfd
|
1
|
|
A case of psoriatic arthritis triggered by SARS-CoV-2 infection, file 249a90ea-836b-4c8c-984b-2ae510799b44
|
1
|
|
Modulation of epitope-specific anti-hepatitis C virus E2 (Anti-HCV/E2) antibodies by anti-viral treatment, file 2d813659-98ee-40ca-8fc9-ddbea9e1251a
|
1
|
|
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients, file 339b80ef-5f7f-4a36-b190-462cc0ebdbec
|
1
|
|
Role and potential therapeutic use of antibodies against herpetic infections, file 3eb97813-5277-4f19-b519-80942c156f30
|
1
|
|
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches, file 51c600ee-1c0b-4698-8170-33ac239c7932
|
1
|
|
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome, file 7b8ab611-eac0-485e-aed2-eaf765f13259
|
1
|
|
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects, file 806c406e-3172-4676-a8bb-37eb2d5fadda
|
1
|
|
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools, file 8dac349b-b0b9-449a-b1cc-c79660470eac
|
1
|
|
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study, file 96450071-a513-4147-a37e-6e50b8f7f2c4
|
1
|
|
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital, file 995be4ca-827a-45f6-9af9-96036c2bdc71
|
1
|
|
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine, file 99db7d1b-a259-4688-bc3f-c199ec5d4842
|
1
|
|
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies, file b1b55b7d-d362-468b-99de-860a90e9a7dc
|
1
|
|
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference, file b488ed4e-ba4f-480f-8704-8b6c356b727e
|
1
|
|
Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs, file d6932674-7f8a-4def-935f-1525c03740f2
|
1
|
|
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity, file e2ae9f11-7b39-4046-a860-cb7d74e349b7
|
1
|
|
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge, file e44337fb-a17c-418b-bab1-7b9e1314f6f9
|
1
|
|
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy, file f32b1698-8776-447b-b134-4e5953daab76
|
1
|
|
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis Virus/HCV pseudotype, file f411bba7-bac5-4896-aa6d-4251db5528ce
|
1
|
|
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections, file f55fb0ae-4367-4160-91a5-8ff0e1a730d1
|
1
|
| Totale |
423 |